Details for New Drug Application (NDA): 018719
✉ Email this page to a colleague
NDA 018719 describes MODRASTANE, which is a drug marketed by Bioenvision and is included in one NDA. Additional details are available on the MODRASTANE profile page.
The generic ingredient in MODRASTANE is trilostane. There are two drug master file entries for this compound. Additional details are available on the trilostane profile page.
The generic ingredient in MODRASTANE is trilostane. There are two drug master file entries for this compound. Additional details are available on the trilostane profile page.
Summary for 018719
| Tradename: | MODRASTANE |
| Applicant: | Bioenvision |
| Ingredient: | trilostane |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 60MG | ||||
| Approval Date: | Dec 31, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 30MG | ||||
| Approval Date: | Dec 31, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
